{
  "question": "\nThe User asks a question, and you solve it. \nYou first generate the reasoning and thinking process and then provide the User with the final answer.\n\nDuring the thinking process, **you can generate python code** for efficient searching, optimization, and computing with the format of starting the python block with ```python. \n**A code query must involve only a single script that uses 'print' function for the output.**. \nOnce the code script is complete, stop the generation. Then, the code interpreter platform will execute the code and return the execution output and error.\n\nIf you lack the related knowledge, you can use the Google Search Tool to search the web and get the information.\nYou can call a search query with the format of <search>your search query</search>, e.g., <search>Who is the current president of US?</search>. The searched results will be returned between <information> and </information>.\nOnce the search query is complete, stop the generation. Then, the search platform will return the searched results.\n\nIf you need to search the web, do not generate code in the same response. Vice versa. You can also solve the question without code and searching, just by your textual reasoning.\n\nOnce you feel you are ready for the final answer, directly return the answer with the format <<<answer content>>> at the end of your response.\nOtherwise, you can continue your reasoning process and possibly generate more code or search queries to solve the problem.\n\n    question: You identified a new ligand-receptor pair initially expressed in the neural crest cells and want to understand the developmental fate of their interaction. The receptor is a monomeric transmembrane barrel with eight alpha helices, four extracellular helices, and three beta sheets that create a binding site for the ligand. The ligand is a coiled-coil of two alpha helices. You create a bicistronic lox-Cre vector with the ligand ORF at the 5' position, fused to mCherry; the receptor ORF is at the 3' and fused to the eGFP at the C-terminus. The ligand is under the CBA promoter, and upstream of the receptor is the IRES regulatory element. Between the ligand ORF and mCherry, there is a stop in a loxP-stop-loxP cassette, and between the receptor and the eGFP, there is a stop in the lox2272-stop-lox2272 cassette. You had also raised antibodies against the overexpressed proteins and now use them to test the construct expression on the Western blot after plasmid transfection to primary astrocyte culture. Total proteins give a signal proportional to the actin loading. You finally breed a mouse model homozygous for your construct in the wt background. You cross it to SOX10-Cre hemizygous mice; after the offspring is born you visualize them under the fluorescent confocal microscope. You do not observe a green signal. Which of the answers below explains the most likely reason for it?\n\nA) the receptor and the eGFP are not in the frame\nB) the receptor-eGFP construct is stuck in the Golgi\nC) the enhancer for the ligand and receptor expression is missing\nD) ligand and the receptor are in a paracrine relationship\n\nOnce you feel you are ready for the final answer, directly return the answer with the format <<<answer content>>> at the end of your response, e.g. <<<C>>>, <<<A>>>\n",
  "response_list": [
    "Here is a thinking process to arrive at the correct answer:\n\n1.  **Deconstruct the Experimental Setup:**\n    *   **Goal:** Understand the developmental fate of a ligand-receptor pair from neural crest cells.\n    *   **Tool:** A mouse model with a conditional expression vector (transgene).\n    *   **Vector Design (Transgene):**\n        *   It's a bicistronic vector, meaning it's designed to express two proteins from a single mRNA transcript.\n        *   **Promoter:** CBA (Chicken Beta-Actin) promoter. This is a strong, generally ubiquitous promoter. Expression is not tissue-specific at the promoter level.\n        *   **First Cistron:** Ligand ORF -> loxP-stop-loxP cassette -> mCherry ORF.\n        *   **Inter-cistronic element:** IRES (Internal Ribosome Entry Site). This allows the ribosome to initiate translation internally on the mRNA, right before the second cistron.\n        *   **Second Cistron:** Receptor ORF -> lox2272-stop-lox2272 cassette -> eGFP ORF.\n    *   **Mouse Cross:**\n        *   Mouse 1: Homozygous for the transgene (`Transgene/Transgene`).\n        *   Mouse 2: Hemizygous for SOX10-Cre (`SOX10-Cre/+`). This mouse expresses Cre recombinase specifically in SOX10-expressing cells (which include neural crest cells and their derivatives).\n        *   **Offspring:** The relevant offspring will have both the transgene and the Cre driver (`Transgene/+ ; SOX10-Cre/+`).\n\n2.  **Analyze the Expected Molecular Events in SOX10-positive cells:**\n    *   The `SOX10-Cre` allele produces Cre recombinase protein.\n    *   Cre recombinase recognizes and acts on lox sites (both loxP and its variant lox2272).\n    *   **Action on First Cistron:** Cre will recognize the two loxP sites, excise the intervening \"stop\" sequence, and leave behind a single loxP site. This should result in a continuous open reading frame (ORF) for a Ligand-mCherry fusion protein. The question doesn't mention the red signal, so we assume this part works or is not relevant to the question.\n    *   **Action on Second Cistron:** Cre will recognize the two lox2272 sites, excise the intervening \"stop\" sequence, and leave behind a single lox2272 site. This is intended to create a continuous ORF for a Receptor-eGFP fusion protein.\n\n3.  **Identify the Problem:**\n    *   **Observation:** No green signal (eGFP) is observed in the offspring.\n    *   **Question:** What is the most likely reason for this failure?\n\n4.  **Evaluate the Answer Choices based on the Molecular Biology:**\n\n    *   **A) the receptor and the eGFP are not in the frame:**\n        *   Let's analyze the consequence of Cre-mediated excision. When a `lox-stop-lox` cassette is removed, a single `lox` site remains in the DNA and subsequent mRNA.\n        *   How long is a lox site (both loxP and lox2272)? A standard lox site is 34 base pairs (bp) long.\n        *   For two proteins to be fused together and both be functional (i.e., for the eGFP to be translated correctly after the receptor), the sequence connecting them must have a length that is a multiple of 3. This maintains the correct reading frame.\n        *   Is 34 bp a multiple of 3? No. 34 divided by 3 is 11 with a remainder of 1.\n        *   This means that the insertion of the 34 bp lox2272 site between the Receptor ORF and the eGFP ORF will cause a +1 frameshift.\n        *   The ribosome will translate the receptor protein correctly, but when it crosses the junction into the eGFP sequence, it will be reading the wrong set of codons. This will result in a garbled amino acid sequence and likely a premature stop codon. No functional eGFP will be made.\n        *   This is a very strong and direct explanation for the complete absence of a green signal.\n\n    *   **B) the receptor-eGFP construct is stuck in the Golgi:**\n        *   The receptor is a transmembrane protein, so it's meant to traffic through the secretory pathway (ER -> Golgi -> plasma membrane).\n        *   If the fusion protein were misfolded and retained in the Golgi, it would still be a Receptor-eGFP protein.\n        *   eGFP can fluoresce in many cellular compartments as long as it's properly folded. We would expect to see green fluorescence localized to a perinuclear, Golgi-like pattern.\n        *   The observation is a complete *absence* of a green signal, not a mislocalization of the signal. So, this option is less likely.\n\n    *   **C) the enhancer for the ligand and receptor expression is missing:**\n        *   The transgene is driven by the CBA promoter, which is a strong, constitutive promoter. It does not rely on the endogenous enhancer of the native gene.\n        *   The tissue specificity of the experiment is achieved not by a specific enhancer, but by the cell-type-specific expression of Cre recombinase (SOX10-Cre).\n        *   Therefore, a missing endogenous enhancer is irrelevant to the expression of this particular transgene. This option is incorrect.\n\n    *   **D) ligand and the receptor are in a paracrine relationship:**\n        *   This describes the biological mode of action (signaling between different cells).\n        *   The problem is a failure to produce a fluorescent protein, which is a technical/molecular issue with the construct's expression.\n        *   Whether the natural interaction is paracrine, autocrine, or juxtacrine has no bearing on whether the Receptor-eGFP fusion protein can be successfully translated and fluoresce. This option is irrelevant to the observed result.\n\n5.  **Final Conclusion:**\n    *   Option A provides the most precise and mechanistically sound explanation for the experimental failure. The 34 bp length of the remaining lox2272 site after recombination is not a multiple of 3, which inevitably causes a frameshift mutation and prevents the translation of the downstream eGFP protein. This is a classic error in designing Cre-inducible fusion protein constructs.\n\n<<<A>>>",
    "Here is a step-by-step reasoning process to determine the correct answer:\n\n1.  **Analyze the Experimental Design:** The goal is to express two fusion proteins, Ligand-mCherry and Receptor-eGFP, in a cell-type-specific manner using the Cre-lox system.\n\n2.  **Deconstruct the Transgene Vector:**\n    *   **Promoter:** CBA promoter. This is a strong, generally ubiquitous promoter, meaning the mRNA for the entire construct will be transcribed in most cells where the transgene is present.\n    *   **Conditional Expression:** The expression of the final fusion proteins is conditional. It depends on the removal of \"stop\" cassettes flanked by lox sites.\n    *   **Cre Recombinase:** The `SOX10-Cre` mouse provides the Cre recombinase enzyme specifically in neural crest-derived cells (the cells of interest).\n    *   **Mechanism of Action:** In SOX10-positive cells, Cre recombinase will be present. It will recognize the loxP sites and the lox2272 sites. It will excise the DNA segment between the two identical sites (the \"stop\" cassette).\n    *   **Post-Recombination Structure:**\n        *   The first cistron will become: Ligand ORF -> single loxP site -> mCherry ORF.\n        *   The second cistron will become: Receptor ORF -> single lox2272 site -> eGFP ORF.\n\n3.  **Focus on the Problem:** The green signal (eGFP) is absent. This means there is a problem with the expression or function of the Receptor-eGFP fusion protein.\n\n4.  **Evaluate the Molecular Consequence of Recombination:**\n    *   The key event is the excision of the `lox2272-stop-lox2272` cassette, which leaves a single lox2272 site in the mRNA, right between the coding sequence for the receptor and the coding sequence for eGFP.\n    *   For two proteins to be fused together and maintain their function (specifically, for the downstream protein, eGFP, to be translated correctly), the sequence linking them must have a length that is a multiple of 3. This is because the genetic code is read in triplets (codons). Any insertion or deletion that is not a multiple of 3 will cause a frameshift mutation.\n    *   A standard lox site (both loxP and its variant lox2272) is **34 base pairs (bp)** long.\n    *   Let's check if 34 is a multiple of 3. 34 divided by 3 is 11 with a remainder of 1.\n    *   Because 34 is not a multiple of 3, the insertion of the 34 bp lox2272 site between the receptor's ORF and the eGFP's ORF will shift the reading frame.\n    *   The ribosome will translate the receptor protein correctly. However, once it crosses the lox2272 sequence and begins translating the eGFP sequence, it will be reading the wrong set of codons. This will result in a string of incorrect amino acids and, almost certainly, a premature stop codon will be encountered. No functional, full-length eGFP protein will be made.\n\n5.  **Assess the Answer Choices based on this analysis:**\n\n    *   **A) the receptor and the eGFP are not in the frame:** This aligns perfectly with our analysis. The 34 bp residual lox2272 site causes a frameshift mutation, preventing the correct translation of eGFP. This is a very strong and direct explanation for the complete lack of green signal.\n\n    *   **B) the receptor-eGFP construct is stuck in the Golgi:** If the protein were being made but was misfolded and retained in the Golgi, we would expect to see a green signal, albeit mislocalized to the Golgi apparatus. The observation is a complete *absence* of signal, making this explanation unlikely.\n\n    *   **C) the enhancer for the ligand and receptor expression is missing:** The transgene is driven by the CBA promoter, a strong, self-contained expression cassette. It does not rely on endogenous enhancers. The tissue specificity comes from the `SOX10-Cre` driver, not the transgene's promoter/enhancer. This is incorrect.\n\n    *   **D) ligand and the receptor are in a paracrine relationship:** This describes the biological mode of signaling between cells. It has no impact on the technical process of translating a fusion protein from an mRNA transcript within a single cell. This is irrelevant to the observed molecular defect.\n\n**Conclusion:** The most likely reason for the absence of a green signal is the frameshift mutation caused by the residual 34 bp lox2272 site left after Cre-mediated recombination.\n\n<<<A>>>",
    "This is a classic molecular biology problem that requires a careful analysis of the genetic construct and the Cre-loxP system. Let's break down the experiment to find the flaw.\n\n### Reasoning and Thinking Process\n\n1.  **Understand the Goal:** The researcher wants to conditionally express two fusion proteins (Ligand-mCherry and Receptor-eGFP) in specific cells (neural crest derivatives) to study their interaction.\n\n2.  **Analyze the Genetic Construct (the Transgene):**\n    *   **Promoter:** It uses the CBA promoter, which is strong and generally active in many cell types. This means the mRNA for the entire construct should be produced in any cell containing the transgene.\n    *   **Conditional Expression:** The key is the \"lox-stop-lox\" system. The stop cassettes prevent the translation of the full fusion proteins. Expression is dependent on the presence of Cre recombinase to remove these stop cassettes.\n    *   **Cre Driver:** The `SOX10-Cre` mouse provides the Cre recombinase enzyme specifically in neural crest cells and their derivatives. This is the \"switch\" that turns on the expression of the fusion proteins in the target cells.\n    *   **The Second Cistron (Receptor-eGFP):** This is where the problem lies. The design is: `IRES - Receptor ORF - lox2272-stop-lox2272 - eGFP ORF`.\n\n3.  **Simulate the Molecular Events in a SOX10-positive cell:**\n    *   The `SOX10-Cre` allele produces Cre recombinase protein.\n    *   Cre recombinase recognizes the two `lox2272` sites in the transgene's DNA.\n    *   Cre performs recombination, excising the \"stop\" cassette located between the `lox2272` sites.\n    *   After this excision, a single `lox2272` site is left behind in the DNA.\n    *   The resulting coding sequence for the second protein is now: `Receptor ORF - single lox2272 site - eGFP ORF`.\n    *   When this gene is transcribed and translated, the ribosome will read through the Receptor's coding sequence, then the sequence of the lox2272 site, and then the eGFP coding sequence.\n\n4.  **Identify the Critical Flaw:**\n    *   For two protein coding sequences (ORFs) to be fused together and result in a functional fusion protein, the reading frame must be maintained. The genetic code is read in triplets of nucleotides (codons). Any insertion or deletion of bases that is not a multiple of three will cause a **frameshift mutation**.\n    *   A standard lox site, including the lox2272 variant, is **34 base pairs (bp)** long.\n    *   Let's check if 34 is a multiple of 3: `34 ÷ 3 = 11 with a remainder of 1`.\n    *   Because 34 is not a multiple of 3, the insertion of the 34 bp lox2272 site between the Receptor ORF and the eGFP ORF shifts the reading frame. The ribosome will translate the Receptor correctly, but after passing the lox2272 sequence, it will read the eGFP sequence in the wrong frame. This leads to the translation of a nonsensical sequence of amino acids and almost certainly a premature stop codon, preventing the synthesis of a functional eGFP protein.\n\n5.  **Evaluate the Options:**\n    *   **A) the receptor and the eGFP are not in the frame:** This is the direct consequence of the 34 bp lox2272 site remaining after recombination. It perfectly explains why no eGFP is produced.\n    *   **B) the receptor-eGFP construct is stuck in the Golgi:** If the protein were being made but was misfolded and retained in the Golgi, you would still expect to see a green signal, just localized to the Golgi apparatus. The observation is a complete *absence* of a green signal.\n    *   **C) the enhancer for the ligand and receptor expression is missing:** The transgene uses the strong, ubiquitous CBA promoter, which does not rely on the native gene's enhancer. The cell-type specificity is provided by the `SOX10-Cre` driver, not the transgene's promoter.\n    *   **D) ligand and the receptor are in a paracrine relationship:** This describes the biological mode of action between cells. It has no bearing on the technical ability of a cell to correctly translate a fusion protein from an mRNA transcript.\n\n**Conclusion:** The most likely reason for the lack of a green signal is a fundamental flaw in the design of the conditional fusion protein. The residual lox2272 site causes a frameshift mutation, preventing the correct translation of eGFP.\n\n<<<A>>>",
    "This is a problem that requires a detailed understanding of molecular biology, specifically the Cre-lox system and the principles of gene expression. Let's break down the experimental design to identify the flaw.\n\n### Reasoning and Thinking Process\n\n1.  **Analyze the Goal and the Tools:** The researcher wants to express a Receptor-eGFP fusion protein in specific cells (neural crest derivatives, marked by SOX10 expression) to track them. The tool is a mouse model with a conditional transgene activated by Cre recombinase.\n\n2.  **Deconstruct the Transgene's Design:** The key part of the construct for this question is the second cistron, which is designed to produce the Receptor-eGFP fusion protein.\n    *   **Initial State (before Cre):** `Receptor ORF` -> `lox2272-stop-lox2272` cassette -> `eGFP ORF`. The \"stop\" cassette contains stop codons in all reading frames, preventing the ribosome from reading through to the eGFP sequence.\n    *   **The \"Switch\":** The system is crossed to a `SOX10-Cre` mouse. In cells expressing SOX10 (like neural crest cells), Cre recombinase will be produced.\n    *   **Action of Cre Recombinase:** Cre recognizes the two identical `lox2272` sites and excises the DNA between them (the \"stop\" cassette).\n    *   **Final State (after Cre):** After recombination, a single `lox2272` site is left behind in the DNA. The coding sequence now becomes: `Receptor ORF` -> `single lox2272 site` -> `eGFP ORF`.\n\n3.  **Focus on the Molecular Consequence (Translation):**\n    *   For a fusion protein to be made correctly, the ribosome must translate the first protein's sequence (Receptor), then the linker sequence (the lox2272 site), and then the second protein's sequence (eGFP), all while staying in the correct reading frame.\n    *   The genetic code is read in triplets of nucleotides (codons). Therefore, any sequence inserted between two coding regions must have a length that is a multiple of 3 (e.g., 3, 6, 9, ... bp). If it's not a multiple of 3, it will cause a **frameshift mutation**.\n    *   We need to know the length of a lox site. A standard lox site (both loxP and its variant lox2272) is **34 base pairs (bp)** long.\n    *   Let's check if 34 is a multiple of 3: `34 ÷ 3 = 11 with a remainder of 1`.\n    *   Since 34 is not a multiple of 3, the 34 bp lox2272 site inserted between the Receptor and eGFP coding sequences will shift the reading frame.\n    *   The ribosome will translate the Receptor protein correctly. However, when it begins to translate the eGFP sequence, it will be reading the wrong set of codons. This will produce a garbled, non-functional amino acid sequence and will almost certainly encounter a premature stop codon, terminating translation. No functional eGFP protein will be synthesized.\n\n4.  **Evaluate the Answer Choices:**\n    *   **A) the receptor and the eGFP are not in the frame:** This is the direct result of the 34 bp lox2272 site remaining after recombination. It perfectly explains the complete absence of a green signal because the eGFP protein is never correctly translated.\n    *   **B) the receptor-eGFP construct is stuck in the Golgi:** If the protein were being produced but was misfolded and retained in the Golgi, you would still see a green signal, just in the wrong location (a bright spot near the nucleus). The problem states there is *no* green signal at all.\n    *   **C) the enhancer for the ligand and receptor expression is missing:** The transgene is driven by the CBA promoter, a strong, independent expression cassette. It does not need an external enhancer. The cell-type specificity is achieved by the `SOX10-Cre` driver, not the promoter.\n    *   **D) ligand and the receptor are in a paracrine relationship:** This describes the biological interaction between cells. It is irrelevant to the technical process of protein translation within a single cell and cannot explain the failure to produce a fluorescent protein.\n\n**Conclusion:** The most likely reason for the failure is a fundamental design flaw in the construct. The residual lox2272 site causes a frameshift mutation, preventing the translation of the eGFP protein.\n\n<<<A>>>",
    "This is a classic molecular biology problem that hinges on understanding the precise consequences of Cre-lox recombination. Let's break down the experiment step-by-step.\n\n### Reasoning and Thinking Process\n\n1.  **Analyze the Goal:** The researcher wants to express a Receptor-eGFP fusion protein specifically in neural crest-derived cells to track them and study the receptor's function.\n\n2.  **Deconstruct the Genetic Construct:** The key part of the construct for this question is the one designed to express the Receptor-eGFP fusion protein:\n    *   **Structure:** `IRES` - `Receptor ORF` - `lox2272-stop-lox2272` - `eGFP ORF`.\n    *   **Mechanism:** This is a conditional expression system. Initially, the \"stop\" cassette (containing stop codons) prevents the ribosome from translating the eGFP portion.\n    *   **Activation:** The system is activated by Cre recombinase, which is provided by the `SOX10-Cre` mouse line specifically in neural crest cells.\n\n3.  **Simulate the Molecular Event:**\n    *   In a SOX10-positive cell, Cre recombinase is present.\n    *   Cre recognizes the two identical `lox2272` sites and excises the DNA between them (the \"stop\" cassette).\n    *   After this recombination event, a single `lox2272` site is left behind in the DNA, and consequently, in the mRNA.\n    *   The new coding sequence becomes: `Receptor ORF` - `single lox2272 site` - `eGFP ORF`.\n\n4.  **Identify the Critical Flaw (The \"Math\" of Molecular Biology):**\n    *   For two proteins (Receptor and eGFP) to be fused together and for the second protein (eGFP) to be translated correctly, the reading frame must be maintained across the junction.\n    *   The genetic code is read in triplets of nucleotides called codons. Therefore, any sequence inserted between two coding regions must have a length that is a multiple of 3 (e.g., 3, 6, 9... base pairs). If the length is not a multiple of 3, it will cause a **frameshift mutation**.\n    *   A standard lox site, including the lox2272 variant, is **34 base pairs (bp)** long.\n    *   Let's check if 34 is a multiple of 3: `34 ÷ 3 = 11 with a remainder of 1`.\n    *   Because 34 is not a multiple of 3, the 34 bp lox2272 site that remains after recombination shifts the reading frame. The ribosome will translate the Receptor protein correctly, but when it starts reading the eGFP sequence, it will be in the wrong frame. This will produce a string of incorrect amino acids and almost certainly encounter a premature stop codon, preventing the synthesis of a functional eGFP protein.\n\n5.  **Evaluate the Answer Choices based on this analysis:**\n\n    *   **A) the receptor and the eGFP are not in the frame:** This is the direct and precise consequence of the 34 bp lox2272 site remaining after recombination. It perfectly explains why no eGFP protein is made and thus no green signal is observed.\n    *   **B) the receptor-eGFP construct is stuck in the Golgi:** If the protein were being made but was misfolded, you would still expect to see a green signal, just mislocalized to the Golgi apparatus. The observation is a complete *absence* of signal, making this explanation incorrect.\n    *   **C) the enhancer for the ligand and receptor expression is missing:** The transgene is driven by the strong, independent CBA promoter. The cell-type specificity comes from the `SOX10-Cre` driver, not a missing enhancer. This is incorrect.\n    *   **D) ligand and the receptor are in a paracrine relationship:** This describes the biological mode of signaling between cells. It is irrelevant to the technical process of protein translation within a single cell and cannot explain the failure to produce a fluorescent protein.\n\n**Conclusion:** The most likely reason for the lack of a green signal is a fundamental design flaw in the construct. The residual lox2272 site causes a frameshift mutation, preventing the correct translation of the eGFP protein.\n\n<<<A>>>"
  ],
  "user_prompt_list": [
    "\nThe User asks a question, and you solve it. \nYou first generate the reasoning and thinking process and then provide the User with the final answer.\n\nDuring the thinking process, **you can generate python code** for efficient searching, optimization, and computing with the format of starting the python block with ```python. \n**A code query must involve only a single script that uses 'print' function for the output.**. \nOnce the code script is complete, stop the generation. Then, the code interpreter platform will execute the code and return the execution output and error.\n\nIf you lack the related knowledge, you can use the Google Search Tool to search the web and get the information.\nYou can call a search query with the format of <search>your search query</search>, e.g., <search>Who is the current president of US?</search>. The searched results will be returned between <information> and </information>.\nOnce the search query is complete, stop the generation. Then, the search platform will return the searched results.\n\nIf you need to search the web, do not generate code in the same response. Vice versa. You can also solve the question without code and searching, just by your textual reasoning.\n\nOnce you feel you are ready for the final answer, directly return the answer with the format <<<answer content>>> at the end of your response.\nOtherwise, you can continue your reasoning process and possibly generate more code or search queries to solve the problem.\n\n    question: You identified a new ligand-receptor pair initially expressed in the neural crest cells and want to understand the developmental fate of their interaction. The receptor is a monomeric transmembrane barrel with eight alpha helices, four extracellular helices, and three beta sheets that create a binding site for the ligand. The ligand is a coiled-coil of two alpha helices. You create a bicistronic lox-Cre vector with the ligand ORF at the 5' position, fused to mCherry; the receptor ORF is at the 3' and fused to the eGFP at the C-terminus. The ligand is under the CBA promoter, and upstream of the receptor is the IRES regulatory element. Between the ligand ORF and mCherry, there is a stop in a loxP-stop-loxP cassette, and between the receptor and the eGFP, there is a stop in the lox2272-stop-lox2272 cassette. You had also raised antibodies against the overexpressed proteins and now use them to test the construct expression on the Western blot after plasmid transfection to primary astrocyte culture. Total proteins give a signal proportional to the actin loading. You finally breed a mouse model homozygous for your construct in the wt background. You cross it to SOX10-Cre hemizygous mice; after the offspring is born you visualize them under the fluorescent confocal microscope. You do not observe a green signal. Which of the answers below explains the most likely reason for it?\n\nA) the receptor and the eGFP are not in the frame\nB) the receptor-eGFP construct is stuck in the Golgi\nC) the enhancer for the ligand and receptor expression is missing\nD) ligand and the receptor are in a paracrine relationship\n\nOnce you feel you are ready for the final answer, directly return the answer with the format <<<answer content>>> at the end of your response, e.g. <<<C>>>, <<<A>>>\n",
    "<information>\nExtra search: </information>",
    "<information>\nExtra search: </information>",
    "<information>\nExtra search: </information>",
    "<information>\nExtra search: </information>",
    "<information>\nExtra search: </information>"
  ],
  "system_message": ""
}